Medicare Enrolled

Dr. Martin Guerrero, M.D.

Psychiatry · El Paso, TX
2311 N MESA ST, El Paso, TX 79902
9152718785
Registered in NPPES since 2007
NPI: 1952591935 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Guerrero from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Guerrero? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Guerrero

Dr. Martin Guerrero is a psychiatry specialist in El Paso, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Guerrero received a total of $1,699,248 from 26 pharmaceutical and/or device companies across 2606 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Guerrero is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $1,699,248 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$1,699,248
Total received (2018-2024)
Avg $242,750/year across 7 years
Top 0% in TX for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
2,606
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$497,858
2023
$377,625
2022
$214,285
2021
$169,617
2020
$59,563
2019
$194,809
2018
$185,489

Payments by company (2024)

Vanda Pharmaceuticals Inc.
$177,730
Neurocrine Biosciences, Inc.
$103,999
Otsuka America Pharmaceutical, Inc.
$81,424
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$46,613
ABBVIE INC.
$30,375
E.R. Squibb & Sons, L.L.C.
$29,533
Axsome Therapeutics, Inc.
$16,969
Alkermes, Inc.
$9,399
Otsuka Pharmaceutical Development & Commercialization, Inc.
$510
Teva Pharmaceuticals USA, Inc.
$337
ACADIA Pharmaceuticals Inc
$320
Lundbeck LLC
$164
Janssen Pharmaceuticals, Inc
$151
Janssen Scientific Affairs, LLC
$105
BioXcel Therapeutics, Inc.
$93
Boehringer Ingelheim Pharmaceuticals, Inc.
$88
Takeda Pharmaceuticals U.S.A., Inc.
$47
Top 3 companies account for 72.9% of 2024 payments
All-time payments by company (2018-2024) ›
Neurocrine Biosciences, Inc.
$284,614
Alkermes, Inc.
$243,408
Otsuka America Pharmaceutical, Inc.
$195,328
Vanda Pharmaceuticals Inc.
$191,105
Allergan Inc.
$177,305
ITI, Inc.
$176,457
Neurocrine BioSciences, Inc.
$94,577
Axsome Therapeutics, Inc.
$89,747
ABBVIE INC.
$76,234
AbbVie Inc.
$51,325
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$46,613
E.R. Squibb & Sons, L.L.C.
$29,533
Allergan, Inc.
$26,283
Otsuka Pharmaceutical Development & Commercialization, Inc.
$11,546
Teva Pharmaceuticals USA, Inc.
$1,961
Janssen Pharmaceuticals, Inc
$982
Lundbeck LLC
$520
ACADIA Pharmaceuticals Inc
$400
Novo Nordisk Inc
$266
Avanir Pharmaceuticals, Inc.
$243
Sunovion Pharmaceuticals Inc.
$242
Janssen Scientific Affairs, LLC
$226
BioXcel Therapeutics, Inc.
$116
Takeda Pharmaceuticals U.S.A., Inc.
$110
Boehringer Ingelheim Pharmaceuticals, Inc.
$88
PFIZER INC.
$18
Top 3 companies account for 42.6% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ARISTADA · AUSTEDO · Aristada 441 mg · Austedo XR · Auvelity · BRINTELLIX · CAPLYTA · COBENFY · COMIRNATY · FANAPT · IGALMI · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · LATUDA · LYBALVI · NAMZARIC · NUEDEXTA · NUPLAZID · Ozempic · REXULTI · SPRAVATO · TRINTELLIX · UZEDY · VRAYLAR · Xultophy 100/3.6
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a psychiatry specialist in El Paso?
Compare psychiatrists in the El Paso area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists in nearby ZIP areas
88
County median income
$58,859
Nearest hospital to ZIP centroid (approximate)
THE HOSPITALS OF PROVIDENCE - MEMORIAL CAMPUS
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Guerrero is a psychiatry specialist, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Guerrero receive payments from pharmaceutical companies?
Yes. Dr. Guerrero received a total of $1,699,248 from 26 companies across 2,606 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Guerrero) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Psychiatrists in El Paso
Browse psychiatrists in El Paso ranked by procedure volume and transparency data.
Highest volume
Top Psychiatrists in TX
Psychiatrists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Psychiatrists in TX
Which TX psychiatrists receive the most from drug and device companies.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
By company
Alkermes, Inc. Payments to Doctors
See all physicians who received payments from Alkermes, Inc.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →